Navigation Links
DaVita Launches 'Flu Fighter Program' in Support of National Influenza Week

EL SEGUNDO, Calif., Dec. 10 /PRNewswire-FirstCall/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), continues to push the Flu Fighters initiative which takes place during the month of December to complement the events of National Influenza Week, Dec. 8 - 14.


The National Influenza Week kicks off this week and is designed to raise awareness of the importance of continuing influenza (flu) vaccination, as well as foster greater use of flu vaccine in December, January, and beyond.

DaVita(R) strives to educate every patient on the benefits of the flu vaccine and hopes to ensure at least 90 percent of patients at every center get vaccinated. Vaccination is one of the most effective interventions available to save lives and prevent hospitalization in dialysis patients. Dialysis patients who already suffer from End Stage Renal Disease are at high risk for the flu, and DaVita hopes this initiative will combat those odds.

Allen R. Nissenson, MD, Chief Medical Officer at DaVita said, "Each year more than 200,000 people are hospitalized for influenza-related complications. Influenza vaccinations are of the highest clinical focus in our company. We want our patients to be as healthy as possible and vaccinations are an opportunity to prevent illness before it starts. It is just one more way to provide for quality patient care and put our patients first."

The flu vaccinations are available at no cost to all DaVita patients and are covered by Medicare. The DaVita Flu Fighters immunization standards are in sync with the Centers for Medicare and Medicaid Services initiative called Healthy People 2010. DaVita expects that more than 90 percent of its patients, as well as direct patient case employees, will be vaccinated to decrease the chances of spreading disease across the dialysis center and to optimize the health of its patients.

DaVita is a registered trademarks of DaVita Inc. All other trademarks are the properties of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit

SOURCE DaVita Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. DaVita Treats Thousands of Dialysis Patients in Wake of Hurricane Ike
2. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
3. Third Annual DaVita Kidney Disease Awareness Walks to Hit 20 Cities in 2008
4. DaVita Introduces Treatment Evaluator
5. DaVita Honored for 4th Year as Training Top 125 Recipient
6. DaVita Announces Retirement of Former Chief Medical Officer Charles J. McAllister, M.D.
7. NxStage Medical Announces Needle Supply Agreement with DaVita
8. DaVita to Present at UBS Best of Americas Conference
9. Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers
10. Axial Biotech Launches Genetic Test for Adolescent Idiopathic Scoliosis (AIS)
11. Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data
Post Your Comments:
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... , June 23, 2016 A person commits a ... crime scene to track the criminal down. An ... Food and Drug Administration (FDA) uses DNA evidence to track ... Sound far-fetched? It,s not. The FDA has increasingly ... support investigations of foodborne illnesses. Put as simply as possible, ...
Breaking Biology Technology:
(Date:6/27/2016)... Research and Markets has announced the addition of the ... offering. The report forecasts the ... at a CAGR of 12.28% during the period 2016-2020. ... analysis with inputs from industry experts. The report covers the market ... also includes a discussion of the key vendors operating in this ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):